Forest sues Teva over Alzheimer’s Drug

Forest Laboratories Inc. have announced filing patent infringement lawsuits against Teva, Barr and others seeking to sell generic versions of Namenda, a treatment for Alzheimer’s disease.

Forest, filed their suit in the U.S. District Court in Delaware, naming  Israel- based Teva Pharmaceutical Industries Ltd,  Barr Pharmaceuticals Inc and India’s Lupin Ltd as defendents.

With annual sales of around 800 million dollars a year, Namenda is a major product for Forest.

The Namenda patent is due to expire in April 2010, but the patentee has applied for an extension until September 2013.



Categories: drugs, Israel, News, Patents, pharmaceuticals, pharmaceuticals and Biotechnology, Teva, US

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: